特殊人群特应性皮炎系统治疗的专家共识
由12名专家组成的小组通过文献综述和改良德尔菲法,针对特应性皮炎合并哮喘、眼表疾病、癌症史、特定感染史、妊娠哺乳及老年这六类临床场景,就传统系统药物、JAK抑制剂和生物制剂的系统治疗选择形成25条专家共识声明。
要点
- 共识覆盖六类特殊人群:合并哮喘、眼表疾病、癌症史、特定感染史、妊娠哺乳及老年。
- 评估药物包括传统系统药、JAK抑制剂和生物制剂三大类。
- 采用改良德尔菲法形成25条专家共识声明。
核心结论
- 专家小组针对六类特殊人群特应性皮炎的系统治疗形成25条专家共识声明并汇总支持数据。
研究设计与样本
- 由12名成员组成的专家小组进行文献综述,经改良德尔菲法形成共识声明。
主要发现
- 文献检索覆盖合并哮喘、眼表疾病、癌症史、特定感染史(含单纯疱疹病毒、带状疱疹、乙型肝炎和结核)、妊娠哺乳及老年六类临床场景。
- 评估的药物包括传统系统药(硫唑嘌呤、环孢素A、甲氨蝶呤和吗替麦考酚酯)、JAK抑制剂(阿布昔替尼、巴瑞替尼和乌帕替尼)及生物制剂(度普利尤单抗、来金珠单抗和曲罗芦单抗)。
关键数值与推荐
- 共形成25条专家共识声明,涉及特殊人群特应性皮炎的系统治疗选择。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With the increasing number of options for the treatment of moderate-to-severe atopic dermatitis, clinicians need guidance on a practical approach to selecting a systemic agent for specific patient populations. We convened an expert panel consisting of 12 members to conduct a literature review and summarize relevant data related to six scenarios of clinical interest: comorbid asthma, ocular surface disease, history of cancer, past and ongoing infections of interest (including herpes simplex virus, herpes zoster, hepatitis B, and tuberculosis), pregnancy and lactation, and the elderly. We performed a literature search and examined each clinical scenario with respect to three major categories of available systemic agents: traditional systemics (azathioprine, cyclosporine A, methotrexate, and mycophenolate mofetil), Janus kinase inhibitors (abrocitinib, baricitinib, and upadacitinib), and biologics (dupilumab, lebrikizumab, and tralokinumab). The expert panel and steering committee met virtually to review the data and discuss the drafted consensus statements. A modified Delphi process was used to arrive at a set of final consensus statements related to the systemic treatment of AD in these specific patient populations. To provide practical guidance on the choice of systemic therapy for atopic dermatitis in these six topics of clinical interest, 25 expert consensus statements and a summary of the supporting data are presented herein.
引用
- Adam DN, Gooderham MJ, Beecker JR, et al. Expert consensus on the systemic treatment of atopic dermatitis in special populations. J Eur Acad Dermatol Venereol. 2023. PMID: 36695072. doi:10.1111/jdv.18922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。